Third Wave's Q1 Revenues Climb 25 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Third Wave Technologies today reported a 25.4 percent increase in first-quarter revenues and an increase in its net loss year over year.
 
The Madison, Wis.-based molecular diagnostics firm generated revenues of $8.4 million for the three months ended March 31, compared to revenues of $6.7 million in the comparable quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.